These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 9618413)

  • 1. Metabolism and transport of the macrolide immunosuppressant sirolimus in the small intestine.
    Lampen A; Zhang Y; Hackbarth I; Benet LZ; Sewing KF; Christians U
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1104-12. PubMed ID: 9618413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of the immunosuppressant tacrolimus in the small intestine: cytochrome P450, drug interactions, and interindividual variability.
    Lampen A; Christians U; Guengerich FP; Watkins PB; Kolars JC; Bader A; Gonschior AK; Dralle H; Hackbarth I; Sewing KF
    Drug Metab Dispos; 1995 Dec; 23(12):1315-24. PubMed ID: 8689938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small intestinal metabolism of the 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor lovastatin and comparison with pravastatin.
    Jacobsen W; Kirchner G; Hallensleben K; Mancinelli L; Deters M; Hackbarth I; Baner K; Benet LZ; Sewing KF; Christians U
    J Pharmacol Exp Ther; 1999 Oct; 291(1):131-9. PubMed ID: 10490896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of the macrolide immunosuppressant, tacrolimus, by the pig gut mucosa in the Ussing chamber.
    Lampen A; Christians U; Gonschior AK; Bader A; Hackbarth I; von Engelhardt W; Sewing KF
    Br J Pharmacol; 1996 Apr; 117(8):1730-4. PubMed ID: 8732283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereoselective metabolism of cibenzoline, an antiarrhythmic drug, by human and rat liver microsomes: possible involvement of CYP2D and CYP3A.
    Niwa T; Shiraga T; Mitani Y; Terakawa M; Tokuma Y; Kagayama A
    Drug Metab Dispos; 2000 Sep; 28(9):1128-34. PubMed ID: 10950860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Properties and regional expression of a CYP3A-like protein in channel catfish intestine.
    James MO; Lou Z; Rowland-Faux L; Celander MC
    Aquat Toxicol; 2005 May; 72(4):361-71. PubMed ID: 15848255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of cytochrome P-450-dependent metabolism and drug interactions of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors lovastatin and pravastatin in the liver.
    Jacobsen W; Kirchner G; Hallensleben K; Mancinelli L; Deters M; Hackbarth I; Benet LZ; Sewing KF; Christians U
    Drug Metab Dispos; 1999 Feb; 27(2):173-9. PubMed ID: 9929499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of interintestinal and intraintestinal variations in human CYP3A-dependent metabolism.
    Paine MF; Khalighi M; Fisher JM; Shen DD; Kunze KL; Marsh CL; Perkins JD; Thummel KE
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1552-62. PubMed ID: 9400033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethosuximide is primarily metabolized by CYP3A when incubated with isolated rat liver microsomes.
    Sarver JG; Bachmann KA; Zhu D; Klis WA
    Drug Metab Dispos; 1998 Jan; 26(1):78-82. PubMed ID: 9443857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidation of 1,8-cineole, the monoterpene cyclic ether originated from eucalyptus polybractea, by cytochrome P450 3A enzymes in rat and human liver microsomes.
    Miyazawa M; Shindo M; Shimada T
    Drug Metab Dispos; 2001 Feb; 29(2):200-5. PubMed ID: 11159812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of DHEA by cytochromes P450 in rat and human liver microsomal fractions.
    Fitzpatrick JL; Ripp SL; Smith NB; Pierce WM; Prough RA
    Arch Biochem Biophys; 2001 May; 389(2):278-87. PubMed ID: 11339818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of CYP3A activities in a subclone of Caco-2 cells (TC7) and human intestine.
    Raeissi SD; Guo Z; Dobson GL; Artursson P; Hidalgo IJ
    Pharm Res; 1997 Aug; 14(8):1019-25. PubMed ID: 9279883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microsomal metabolism of delavirdine: evidence for mechanism-based inactivation of human cytochrome P450 3A.
    Voorman RL; Maio SM; Payne NA; Zhao Z; Koeplinger KA; Wang X
    J Pharmacol Exp Ther; 1998 Oct; 287(1):381-8. PubMed ID: 9765359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Description of a 96-well plate assay to measure cytochrome P4503A inhibition in human liver microsomes using a selective fluorescent probe.
    Chauret N; Tremblay N; Lackman RL; Gauthier JY; Silva JM; Marois J; Yergey JA; Nicoll-Griffith DA
    Anal Biochem; 1999 Dec; 276(2):215-26. PubMed ID: 10603245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Midazolam and triazolam biotransformation in mouse and human liver microsomes: relative contribution of CYP3A and CYP2C isoforms.
    Perloff MD; von Moltke LL; Court MH; Kotegawa T; Shader RI; Greenblatt DJ
    J Pharmacol Exp Ther; 2000 Feb; 292(2):618-28. PubMed ID: 10640299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The contribution of intestinal and hepatic CYP3A to the interaction between midazolam and clarithromycin.
    Gorski JC; Jones DR; Haehner-Daniels BD; Hamman MA; O'Mara EM; Hall SD
    Clin Pharmacol Ther; 1998 Aug; 64(2):133-43. PubMed ID: 9728893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation of intestinal and hepatic cytochrome P450 3A activity with use of midazolam as an in vivo probe: effect of ketoconazole.
    Tsunoda SM; Velez RL; von Moltke LL; Greenblatt DJ
    Clin Pharmacol Ther; 1999 Nov; 66(5):461-71. PubMed ID: 10579473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential metabolism of midazolam in mouse liver and intestine microsomes: a comparison of cytochrome P450 activity and expression.
    Perloff MD; Von Moltke LL; Greenblatt DJ
    Xenobiotica; 2003 Apr; 33(4):365-77. PubMed ID: 12745872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of ketoconazole on the intestinal metabolism, transport and oral bioavailability of K02, a novel vinylsulfone peptidomimetic cysteine protease inhibitor and a P450 3A, P-glycoprotein dual substrate, in male Sprague-Dawley rats.
    Zhang Y; Hsieh Y; Izumi T; Lin ET; Benet LZ
    J Pharmacol Exp Ther; 1998 Oct; 287(1):246-52. PubMed ID: 9765344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereoselective metabolism of cisapride and enantiomer-enantiomer interaction in human cytochrome P450 enzymes: major role of CYP3A.
    Desta Z; Soukhova N; Morocho AM; Flockhart DA
    J Pharmacol Exp Ther; 2001 Aug; 298(2):508-20. PubMed ID: 11454912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.